Northwest Biotherapeutics (NWBO) Asset Utilization Ratio (2011 - 2026)
Northwest Biotherapeutics' Asset Utilization Ratio came in at 0.03 for Q2 2026, down 27.4% from 0.04 a year earlier but up 50.1% from the prior quarter.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Going back to Q3 2011, Northwest Biotherapeutics' Asset Utilization Ratio data covers 60 quarters.
- Going back by year, Asset Utilization Ratio was 0.05 in FY2024 (-22.4%), 0.07 in FY2023 (+38.6%), 0.05 in FY2022 (+71.2%) and 0.03 in FY2021 (-53.6%).
- The five-year range for quarterly Asset Utilization Ratio is 0.02 (Q1 2026) to 0.07 (Q3 2023).
- Year-over-year, Asset Utilization Ratio has declined for five consecutive quarters, with an average decline of 31.3% over the last eight quarters.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q1 2023 (growth of 103.8%), and the weakest in Q1 2026 (a decline of 65.8%).
- Business Quant data shows NWBO's Asset Utilization Ratio at 0.02 (Q1 2026), 0.02 (Q4 2025) and 0.03 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.37 Bn | 1,134.95 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 643.27 Bn | 563.13 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 358.37 Bn | 312.75 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 301.91 Bn | 265.90 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 267.33 Bn | 241.01 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 241.44 Bn | 196.84 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 193.00 Bn | 167.20 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 171.57 Bn | 118.21 Bn | 10.94 Bn | 0.31 |
| 10 | Northwest Biotherapeutics | 252.94 Mn | 242.95 Mn | - | 0.03 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.03 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.05 |
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | 0.06 |
| Jun 30, 2024 | 0.06 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.07 |
| Sep 30, 2023 | 0.07 |
| Jun 30, 2023 | 0.06 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.03 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.05 |
API Access
Northwest Biotherapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();